Cart
sales@molnova.com
SB 265610
CAS No. 211096-49-0
SB 265610( SB265610 | SB-265610 )
Catalog No. M13354 CAS No. 211096-49-0
A potent, selective, reversible CXCR2 antagonist with with Kd of 3.48 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 110 | In Stock |
|
| 10MG | 177 | In Stock |
|
| 25MG | 356 | In Stock |
|
| 50MG | 530 | In Stock |
|
| 100MG | 759 | In Stock |
|
| 500MG | 1557 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSB 265610
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, reversible CXCR2 antagonist with with Kd of 3.48 nM.
-
DescriptionA potent, selective, reversible CXCR2 antagonist with with Kd of 3.48 nM; inhibits protein nitration induced by hyperoxia, reduces radical formation in hyperoxia-exposed newborn rat lung; also induces G1 arrest, ans shows anti-proliferative activity in in IL8-rich tumor microenvironments.
-
In Vitro——
-
In VivoAnimal Model:MMTV-PyVmT/Tgfbr2MGKO and MMTV-PyVmT/Tgfbr2flox/flox tumors from donor mice Dosage:2 mg/kg/day Administration:Intraperitoneal injection; daily; for two weeks Result:Significantly inhibited the recruitment of Gr-1+CD11b+ cells to the mammary adenocarcinoma.
-
SynonymsSB265610 | SB-265610
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorChemokine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number211096-49-0
-
Formula Weight357.16
-
Molecular FormulaC14H9BrN6O
-
Purity>98% (HPLC)
-
Solubility100 mM in DMSO
-
SMILESO=C(NC1=C2N=NNC2=C(C#N)C=C1)NC3=CC=CC=C3Br
-
Chemical NameN-(2-Bromophenyl)-N'-(7-cyano-1H-benzotriazol-4-yl)urea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. de Kruijf P, et al. J Pharmacol Exp Ther. 2009 May;329(2):783-90.
2. Bradley ME, et al. Br J Pharmacol. 2009 Sep;158(1):328-38.
3. de Kruijf P, et al. Mol Pharmacol. 2011 Dec;80(6):1108-18.
4. Goda AE, et al. Anticancer Res. 2015 Jun;35(6):3235-43.
molnova catalog
related products
-
AZD 1678
AZD 1678 is a potent, selective orally bioavailable CCR4 receptor antagonist with pIC50 of 8.6 for hCCR4, pIC50 of 9.0 for rCCR4.
-
LMD-009
LMD-009 (LMD 009, LMD009) is a potent, selective, nonpeptide CCR8 agonist.
-
Plerixafor
Plerixafor (JM-3100, AMD-3100, SID-791) is a potent, selective CXCR4 inhibitor.
